Abstract
ADHD can be viewed as a precursor or liability for conduct problems and other externalizing conditions. Despite its familiarity, develoments in the past decade suggest that refining the phenotype will yield dividends for clinical prediction and treatment specification as well as mechanistic discovery and theory. ADHD is a useful category yet comprises multiple constitutive traits requiring further specification. The field is nowpoised to shift to a useful integration of novel dimensional traits into the ADHD phenotype. This shift will need to recognize the importance of both the established ADHD symptom dimensions and other dimensions, to create new presentations, types, or specifiers in the nosology. Clinical issues include the role of sluggish, disengaged cognitive style of inattention with hypo-actiivity. Dispositionasl traits related to emotional dysregulation will be key as well; these include negative affect and irritability (anger dysregulation). In In the cognitive sphere, alolng with ongoing work on executive functions and reward discounting, new insights related to cognitive information gain or neural gain (a mechanism by which relevant neural connections strengthen during rapid information uptake and decision making) may explain other cognitive findings and relate to dispositional traits and clinical features. Due to its early gateway role, clinical prediction algorithms to evaluate course of ADHD and advisability of intervention will be valuable. A neurodevelopmental understanding, with very early developmental origins and seeing ADHD as an early precursor of more serious complications later, opens opportunities for early preventive support and early detection drawing on non-clinical trait measures as risk indicators. An emerging focus on early origins from conception forward is informing understanding of etiology and will continue to do so in valuable ways. Clinical prediction algorithms should benefit from inclusion of low cost, readily deployable trait measures discussed here including selected temperament and cognition measures, which appear to enhance predictive power.
Severe problems with inattention/disorganization, impulsivity, and hyperactivity constitute the ADHD syndrome as currently understood. Yet this population is highly heterogeneious, and progress over the past decade commends further phenotype refinement to maximize clinical prediction, treatment matching, and mechanistic understanding. I illustrate this in work on dispositional trait ratings (i.e., temperament and personality), and attention/cognition in the laboratory. These domains provide unique opportunities for novel cross cutting phenotype dimensions using low cost, field-deployable measures.
The importance of progress on ADHD is difficult to overstate. Because when mild ADHD is difficult to distinguish from typical child behaviors and stimulant treatment often contains symptoms, its seriousness can be under-appreciated. Yet, when extensive enough to markedly interfere with developmental tasks (learning, peer relations) as required in DSM-5, ADHD is remarkably important due to early onset, role as a potential causal precursor to other mental health conditions (1–3), including elevated risk for future depression, anxiety disorders, psychosis (4–6) as well as cascading poor outcomes including elevated risk for homelessness, unemployment, and poor health (7), culminating in reduced average lifespan or premature death due to accident, suicide, or degraded physical health (8). In all, despite benign outcomes in a subset of cases, ADHD is a major public health concern (1, 6, 9). Poor outcomes typically reflect a developmental progression from ADHD to oppositional defiant disorder (ODD), rule breaking, aggression (conduct disorder), mood disorder, and addiction, with continued impulsivity and poor executive function (EF) (10). Thus, ADHD in childhood is a critical early risk phenotype.
Over the past two decades, ADHD is increasingly seen as a disorder of self-regulation rather than inattention per se, but that idea requires careful elucidation (11) as phenotype refinement is considered. In maintaining a developmental perspective, I focus on childhood with only passing reference to adulthood, where issues and considerations shift considerably. After summarizing ancillary issues and clinical phenotype concerns, I introducing a dynamic developmental lens, then I examine (a) key constitutive traits and (b) evolving ideas about neurocognition, before offering conclusions.
Issues in the field affected by phenotype selection and bypassed here.
Cross cutting trait dimensions are necessary to address heterogeneity and that in turn is necessary in nearly every area of ADHD research. Some of the most active areas include (a) The genetics (12, 13) and neuroscience (14–16) of ADHD, as well as the exploding field of early epigenetic changes and ADHD (17–20); (a) Concerns about stigma, the vocabulary of neurotypicality versus the vocabulary of disorder, and whether changes in nomenclature are in order; (c) Gender and sex differences, including hormone effects and differential sex and gender responses to environmental insults (21–24), including distinct risk profiles and clinical needs (25); (d) Race and ethnic differences in ADHD treatment availability, utilization, and biases in diagnosis and intervention even as the demographic picture evolves (26–29); (d) Interest in alternative treatments and new information on nutrition, lifestyle, and health linkages to psychological problems and ADHD (30, 31); (e) New work on ADHD course, including frequency of offset, onset, or recurrence as well as late onset (32, 33). (f) In the externalizing sphere, ongoing work on the dimension of callous-unemotional trait(s) and the degree of mechanistic relation to adult psychopathy (34, 35) also has relevance to ADHD profiles (36, 37) though space prevents elaboration herein. I have not even nodded to various developments in pharmacogenetics, psychosocial treatments, work on ADHD and autism spectrum disorder, and more. All of these testify to the dynamism in current ADHD research and all require clarity about the phenotype and an approach to heterogeneity in the population.
Focus herein.
I therefore focus here on the over-arching and cross-cutting issue of the integration of related dimensions, traits, and disorder categories, which informs the meta-issue of within-syndrome heterogeneity and across-syndrome relations. The issue of dimensions versus categories has been a fundamental concern of nosologists for a century including the RDoC and HITOP efforts more recently as well as historical and current empirically derived problem dimensions in child psychiatry (38–43). Categories are inescapable in a clinical decision context, yet ADHD symptoms are more reliable and valid when studied as dimensions than as a category (44). Subtyping by novel trait profiles is a promising hybrid approach for integrating category and dimension as I will describe.
The Clinical Level
ADHD and Externalizing.
ADHD is highly correlated with externalizing disorders (conduct (CD), oppositional defiant (ODD), and substance use but including key behavioral domains of aggression, rule breaking, and callous-unemotional traits). However, ADHD is best seen as developmental precursor rather than a parallel outcome or manifestation of externalizing (10, 45). Therefore, ADHD was moved in DSM-5 to a neurodevelopmental category due to early onset prior to externalizing disorders; neuroimaging findings showing alterations in brain development from early life forward, and overlap with neurodevelopmental disorders such as autism and learning disorders (46, 47); the past decade has seen massive literature exploring early neurodevelopmental roots and correlates consistent with that decision. Yet some externalizing features, like irritability and high aggression, are also apparent early in life, with neurobiological correlates (48, 49), and can be defended as neurodevelopmental (50), adding some complexity to this evolving picture.
Etiological distinctiveness.
Reflecting the developmental picture, ADHD has a partially distinct etiological structure from externalizing behaviors like conduct problems. For example, a substantial literature documents a social learning component for aggression and conduct problems, though not as much for callous-unemotional traits but see (35). Antisocial behavior tends to have only modest heritability of around .5 (51), with important influences of shared environment (although aggression and rule breaking appear to have distinct etiological influences (52)). ADHD in contrast has heritability in the .7–8 range and modest non-shared environment (as well as GxE interaction) as the suggested causal structure (12, 53, 54). Parenting behaviors are associated with ADHD even apart from co-occuring externalizing problems and participate in the dampening or amplification of ADHD symptoms (55, 56). This is partly due to parent ADHD as well as partly due to youth ADHD symptoms evoking parenting responses (genotype-environment correlations (57). However, the idea that parent behaviors are a primary cause ADHD has been refuted both by behavioral genetic studies showing high heritability and minimal shared environment effects (53), and clever experimental tests (58).
Yet, even with high heritability in view, early environmental effects are important in ADHD. They may mediate genetic susceptibility, interact with genotype (such interactions can be hidden in the heritability term), or account for non-shared environment variance. None are specific or unique to ADHD but among the candidates deserving further causal and mechanistic investigation are prenatal maternal stress and distress (59), pre-term birth and/or low birth weight (60–62), social disadvantage and adversity and its mediators (63), typical (relatively low) level lead exposure (64–66), and other early yet widespread environmental toxicants (67, 68). Although many such findings rely on observational designs vulnerable to unmeasured confounders including genetic transmission (genotype-environment correlation)(69), causal evidence can be sought in sibling comparisons, Mendelian randomization, and other designs. Thus, a causal role is called into question for maternal smoking (70) and pre-pregnancy maternal BMI (71), but supported for average level lead exposure (65), social disadvantage (72), and low birth weight (70). in ADHD. Studies also support an additive role of early insults and genetics (73) while confirming confounding by ancestry for many exposures (74).
Overall, the developmental picture remains that early emerging hyperactivity-impulsivity (and possibly inattention), perhaps in conjunction with irritability, form an early liability phenotype for the emergence of aggression/conduct problems in the presence of particular socialization context, and that ADHD is part of a causal chain for other later emerging psychological problems and conditions, despite bidirectional effects (75). This heightens ADHD’s importance for early primary and secondary prevention of mental health conditions.
ADHD presentations/subtypes.
Here, the key node for clinical phenotype refinement concerns the ADHD-inattentive presentation (ADHD-IN). The ADHD subtypes of DSM-IV were downgraded in DSM-5 to presentations (44) due to the developmental instability of the then-subtypes. Indeed, the inattentive and combained (ADHD-C) presentations of ADHD are, in many respects, essentially severity categories. (The hyperactive presentation, ADHD-H, is rare after preschool but also typically milder than ADHD-C on external correlates). Differential validity with relation to academic and externalizing problems holds better for the dimensions than the presentations, because presentations can change. However, ADHD-IN is critically heterogeneous.
In DSM-III, ADD-without hyperactivity (ADD-W/O) was described with low activity, sluggish tempo, daydreaming. The limited research on that group in the 1980’s suggested important differences from ADD+H (76). However, In DSM-IV, these symptoms were dropped (77); the new ADHD-IN type presumably encompassed the hypoactive group. Yet, ADHD-IN captures both children who are over-activite yet insufficient to meet ADHD-C, and those who are hypo-active. Although considered for DSM-5 under the rubtic of a so-called restrictive inattentive group, DSM-5 did not address this problem due to lack of data. In the past decade, a large body of work suggests the hyporactive, sluggish, daydreaming features indicate a different profile or group from the remainder of children with ADHD (78). This entire body outlines the potential validity of a dimension or a category of youth with sluggish cognitive tempo, now called cognitive disengagement syndrome (CDS), characterized by excessive daydreaming, mental confusion, and hypoactivity (Becker (79) provides a thorough review).
This group is distinct from ADHD-C and ADHD-IN with regard to associations with depression, anxiety, and particular kinds of sleep problems, and possibly distinct cognitive profiles (80). Yet comparative studies have generally not controlled well for co-occuring hyperactivity level or looked at a restrictive ADHD-IN group. When this has been done, differentiation from the restrictive ADHD-inattentive subgroup of ADHD-IN is unclear (81–83). Overall, this suggests the likelihood of a clinically important yet distinct profile hidden within the ADHD population as currently defined in DSM-5, which may be ultimately the same or related to the CDS syndrome, likely needs to either be recognize either as a separate disorder, a subtype, or a specifier. Clarifying the appropriate nosology of CDS and a potential ADHD restrictive inattentive profile, is needed to reduce clinical heterogeneity (79).
Development
ADHD as gateway phenotype.
As already alluded to, ADHD and externalizing problems are (like most psychological problems and psychopathology) not static entities but are developmentally dynamic, contextualized features of mental and behavioral life (for a theoretical elaboration see (42)). As noted, ADHD participates as an early feature in a developmental progression that sometimes continues into ODD, CD, and later depression, substance use, and other probolems. ADHD is a bellweather: a phenotypic precursor to externalizing –and often, internalizing--problems, depending on moderating developmental contexts.
Early Origins.
What of the origins of ADHD itself? The past decade has seen growing interest in the developmental origins of psychological problems including ADHD, suggesting the possibility of finding biomarkers or early risk factors and mechanisms during pregnancy. For example, a body of work relates maternal emotional distress during pregnancy to offspring psychological and behavioral problems including ADHD (84–86). Other work, including in our lab with Elinor Sullivan, suggests that maternal systemic inflammation is one mediator of this association (87–89) and that maternal exposures, such as poor diet or emotional duress or trauma appear to alter offspring temperament (90) (Non-human epigenetic studies also note paternal exposures can affect offspring later, but such research is nascent in humans). Infant negative affectivity, including irritability, is related to maternal systemic inflammation (88),and also in turn predicts elevated ADHD-related symptoms and problems prospectively by age 5–6 years in work from the same group (91). All are now being followed up in larger cohorts via the HBCD study.
The findings exemplify that the field of early origins of ADHD is rapidly expanding with the establishment of a multi-site, international consortium looking at biological, physiological, and genetic markers, neural development, as well as behavioral and emotional factors, during pregnancy and at delivery (92). Overall, we may speculate that ADHD’s earliest roots during pregnancy include a range of biological programming responses to emotional or physical stressors on the mother or fetus, on top of genotype. These in turn are mediated via placental gene expression and other mechanisms (87, 93), likely including epigenetic effects (18, 19, 94). This in turn sets the stage for early temperament precursors such as negative emotionality, irritability, and high activity. These in turn initiate a developmental cascade toward ADHD and secondary complications later. If true, such a cascade would open multiple opportunities for early supportive preventive intervention. We (45) provide an updated developmental account, which relies on and modestly elaborates work by others, particularly Rothbart e.g. (95).
Precursive Trait dimensions.
Here, just as ADHD is a precursor to externalizing (which in turn depends on a range of moderating environments), temperament is a precursor to the emergence of ADHD depending on moderating and mediating traits and socialization. (When temperament is defined in relation to behavioral traits or typically expressed emotions and incentive responses and their regulation, the fields of temperament and personality largely agree on the value of at least two major and partially orthogonal yet mutually inhibiting domains denoting positive and negative valence [sometimes generalized as extraversion and neuroticism, or as approach and avoidance incentive responding; see text], which then can be analyzed behaviorally into narrower component domains of behavioral and affective tendencies.) As to higher order traits, both negative and positive emotionally play a role empirically and conceptually. For example, anger reactivity in the infant and toddler periods predicts childhood ADHD symptoms longitudinally (96–99), possibly mediated by disrupted inhibitory control (96). (While anger reactivity is an approach emotion [frustrative approach] rather than avoidance, in factor analytic studies of temperament scales based on positive and negative emotions, it factors with negative emotions such as fear and sadness; thus I here link it to negative emotionality at the observational level.) Positive affect/high approach in infancy predicts child ADHD symptoms as well (98, 100–103). Also consistent with the model are findings that after toddlerhood, at 36 months of age, lower effortful control best predicts later ADHD (104, 105), though more studies are needed to confirm the mediational hypothesis. Figure 1 depicts one hypothesized developmental cascade.
Figure 1.
Hypothesized schematic of one developmental pathway to ADHDa
aPrenatal stressors on pregnant mother or preconception biology of mother or father can be emotional distress or physical insult/illness; biological pathways during gestation are more complex than schematized here; infant affect can be overlapping but could distinguish different pathways to temperament profiles later. Mediation by low effortful control needs more verification. Further discussion in Reference #(45).
Stages of development for ADHD are depicted in a series of blocks on the diagram. Arrows show developmental sequences.
Summary.
While moderation by caregiving is crucial to a final developmental model (reviewed in (45)), this picture fits conceptually with an idea of distinct developmental pathways leading to distinct developmental profiles within an ADHD population defined by variations in emotional regulation, with positive versus negative emotionality playing key roles in defining the profile. I consider these possible profiles within an ADHD-defined group next.
ADHD and dispositional traits: profiles and secondary outcomes
Consistent with the early developmental literature, over the past two decades an expanding literature has established that ADHD (like externalizing generally) is related to a mix of personality and temperament traits including low effortful control/conscientiousness or high impulsivity; high positive emotionality (or extraversion) in most studies, high negative emotionality (or neuroticism), and in some studies, low agreeableness (hostility); differential trait associations are observed for hyperactivity/impulsivity and inattention (106–113). To move forward with these findings and capitalize on them, careful consideration of heterogeneity of profiles (that is, trait combinations) within individuals meeting an ADHD criterion is needed.
Although ADHD is unsurprisingly and somewhat obviously related to traits like impulsivity, under-control, and low self-control, with which it shares overlapping conceptual and behavioral space, it is negative emotionality that most saliently moderates variation in ADHD outcome. The component trait of anger dysregulation or irritability is crucial here. Irritability often factors with negative emotions although neurobiologically it is conceived of as an approach not an avoidance response(114). Irritability cuts across multiple DSM-5 conditions including DMDD, CD, ODD and ADHD and others. It is a precursor in early life to multiple child behavioral problems future problems and psychopathology generally (49), including ADHD, depression, anxiety, and externalizing problems. Although DMDD is the prototypical disorder of irritability, many children with ADHD have marked problems with irritability yet fall short of a DMDD diagnosis.
A series of papers using the Oregon-ADHD-1000 cohort of well-characterized community-recruited children with and without ADHD at intake (115) has clarified the importance of this domain for ADHD. Cross sectionally, irritability is strongly related to ADHD even in the absence of conduct disorder, even after adjusting for ODD symptoms, and when severity is insufficient to meet criteria for DMDD (116). A subgroup of children with ADHD with very high irritability+negative affect is reliably able to be identified through computational person-based strategies (117). Figure 2 shows a typical finding with explanatory notes. In Figure 2, the irritable group had worse clinical outcomes when followed up one to two years later than other children with equally severe ADHD. These include much higher rates of new onset of anxiety disorder, depression, and worsening ADHD and externalizing problems in the future—and this prediction was stronger than one relying only on the usual clinical indicators of ADHD severity or baseline comorbidity (117). Similar results were replicated in other groups—an emotionally dysregulated group is universally identified, with a high NA/irritable group most replicable and a surgent group nearly so (117–122).
Figure 2.
Three temperant profiles within ADHDa
aThese illustrative data illustrate the large differences between three temperament profiles of children all meeting criteria for ADHD, defined by mathematical grouping of similarity on a set of temperament scales from the TMCQ (Rothbart Temperament in Middle Childhood Questionnaire). A matched group of typically developing children are represented with a zero-score on the chart; all the ADHD group scores are thus standardized to that group. Note that both the Surgent and Irritable ADHD groups have elevated anger relative to typically developing children, but this is more extreme in the irritable group, and the irritable group has slow recovery (high unsoothability) along with more negative emotions generally. In contrast, the surgent group has low shyness or high sociability, as well as far higher scores on high intensity pleasure and assertiveness. These results were not fully explained by selection of ADHD severity (similar levels of ADHD symptoms), subtype, gender/sex, or comorbid disorders. The squares are approximately the size of the +/− 1 standard error range around the data point, thus group separation is large. Data from Reference #(117).
Three lines represent three groups of children with ADHD who differ in their emotional styles. The blue line is a group of typically developing children. The typical developing group is at zero and the squares represent the standard errors, showing that group differences are large on these trait measure.
Exemplifying the value of a multi-dimensional approach to clinical prediction and psychopathology (rather than static categories), longitudinal network modeling of a well characterized prospective sample enriched for ADHD (115) showed that dimensionally measured irritability, working memory weakness, and severity of ADHD symptoms emerged as independent and additive predictors of risk for future worse psychopathology, particularly for future depression and ODD (123). Further, we also demonstrated that the ADHD polygenic score was related to irritability and emotional dysregulation generally just as strongly as it was to ADHD symptoms; and a group with ADHD+ high irritability had a higher ADHD polygenic score than ADHD with typical emotional responding (124) or any other subgroup of youth with ADHD or ADHD sub-profile (including ADHD+ODD). In that sample selected to over-represent ADHD, the ADHD polygenic score but not the depression or bipolar polygenic score was related to the emotion regulation traits and ADHD (note that the polygenic score findings might not generalize to a sample not selected for ADHD).
As shown in Figure 2, this work also identifies a group of youth meeting criteria for ADHD who have only mildly elevated anger but extremes of positive approach emotions—activity level, sociability, excitability. This group was at only mildly elevated risk of worsened outcomes over and above other youth with or without ADHD. Various replication studies have suggested that an emotionally dysregulated subgroup with elevated negative emotions is highly replicable in ADHD samples, while the positive-emotion dysregulation group is only sometimes able to be observed in these cluster-analysis type of studies. Crucially, these groups are not necessarily showing more severe levels of ADHD symptoms—so these studies are not merely recovering mild versus severe cases.
All of this suggests that conceptualizing a refined ADHD phenotype to integrate emotional dysregulation, including negative emotionality and irritability, in some form, (as suggested long ago by Barkley, (125)), would dovetail with etiological structure as well as assist in clinical prediction. Such a refined analysis of the ADHD phenotype(s) may have etiological and clinical value as profiles, perhaps superior to existing DSM-presentations. It is helpful that the major traits have well-developed theory and literature related to neurobiology as well, helping advance integration.
Admittedly, introducing emotional dysregulation as a feature of ADHD in the nosology would not be without complications. For example, it would risk opening up ADHD again to be an over-inclusive category like the old category of minimal brain dysfunction or MBD. It could create confusion about when to add comorbid diagnoses for treatment. Yet a well-defined sub-profile approach could open new insights for research as well as clinical strategies and reduce over-assignment of multiple disorders when not necessary. It could reduce clinical confusion about diagnostic assignment in complex ADHD cases. To avoid the many complexities of overhauling the ADHD diagnostic criteria, an available interim step in a future DSM would be to include a specifier for ADHD with elevated levels of anger reactivity or extreme emotional dysregulation that is short of criteria for a DMDD diagnosis.
Thus, as we look ahead, elaborating on the relative importance of emotional dysregulation in ADHD even in the absence of a frank comorbid anxiety or mood disorder, and of irritability (anger dysregulation) as a component of that general emotional dysregulation, will be helpful in formulating the optimal clinical as well as descriptive strategy, though it requires further definitional work. As the field works to integrate trait dimensions into the existing nosology (with its categories intended to facilitate clinical decision making), traits of temperament related to emotional dysregulation and regulation appear to be particularly helpful in the case of ADHD, and warrant close consideration.
Cognition and ADHD: Self-Regulation, Alertness/Arousal, and Executive Function
A second fruitful arena for low cost and mechanistically valuable phenotype refinement lies with lab assays of cognition and attention. I consider lab assays because they balance the generality and reliability of trait ratings with controlled measurement not subject to rater bias. Executive functioning, reward discounting, and arousal are central and rapidly evolving construcs here. If ADHD is a disorder of self-regulation, then dysregulation of impulse, emotion, and attention makes sense--the neural circuits that support regulation of action and of emotion are closely related (126, 127) and in turn rely on the regulatory role of attention (128, 129).
Executive functions (EF) include response suppression (response inhibition), working memory, planning, task switching, and others effortful or deliberate cognitive functions. Cognitive control--ignoring distraction and adapt attention to task demands; sometimes referred to as self-control or effortful control to include suppressing an impulse to sustain goal behavior. This control function emerges toddlerhood in precursive form and is a foundation for more complex executive functions later in childhood (130). Self-regulation is broader than EF because it encompasses both deliberate or effortful strategies to regulate behavior and emotion like suppressing an impulse or planning and (b) relatively automatic regulatory processes. It also involves (c) social supports (indeed, in early life regulation is heavily dependent on extrinsic supports such as caregiver behaviors). For conceptual elaboration see (11).
Laboratory-measured EFs like working memory and response inhibition/suppression have modest yet reliable associations with ADHD in meta-analyses. Impulsivity is multicomponential, but one aspect measured in the lab is temporal discounting of future reward. Meta-analysis suggests a modest but reliable ADHD-effect of steepened reward discounting gradient (131) and problems with neural reward systems (typically conceived in relation to meso-limbic dopamine circuits) are among the most common proposals for a mechanistic breakdown in ADHD (10, 132).
Most striking in the past decade is a resurgence of computational studies related to arousal. The linkage to personality traits is of interest before proceeding. Arousal was of interest in cognition and central to theories of personality traits in the 20th century (135, 136). For example, Zuckerman’s (137) sensation seeking, like Eysenck’s extraversion, was related to low cortical arousal leading to stimulation-seeking behavior to optimize arousal state. Gray (138, 139) linked arousal directly to incentive-specific arousal systems--the behavioral inhibition (BIS) and behavioral approach (or activation) system (BAS). Most of these arousal-based trait theories were related to psychopathy or antisocial behavior or conversely to anxiety, with little mention of ADHD (or its predecessors)(140). However, Quay (141, 142) proposed that ADHD was related to underactivity of Gray’s BIS; various reward response theories are relatead to Gray’s BAS though do not always make the connection. In the 1970’s, Satterfield, Zentall, and others (143–145) proposed that ADHD was characterized by sub-optimal central arousal leading to both hyperactivity and inattention, but without reference to personality theory. This century, Soderlund and colleagues (146–148) proposed an updated optimal stimulation/moderate brain arousal theory of ADHD that has been generative.
However, arousal, which encompasses autonomic systems (sympathetic and parasympathetic) as well as multiple neural circuits, has historically been critiqued due to under-specification and inconsistent physiological measurement results (140). The concept is clarified for ADHD when defined as alertness, as suggested by Petersen and Posner (151). Alertness here is modulated by ascending NE neurons from the locus coeruleus to the cortex (the LC/NE circuit). (Noted that alertness is also modulated by dopamine, phasic cholinergic responding and glutamatergic states (152, 153) and other neural circuits (154–156)). The ascending LC/NE system plays a critical role through a process of neural gain, reflected neurally in selective firing and suppression of neural circuits, and reflected cognitively in improved signal: noise ratio during fast decision tasks (153, 157, 158). Neural gain reflects the strength of neuronal response to signal and is correlated with informational gain during attention and decision tasks. It can be proposed as an integrative step for ADHD cognition and attention (159).
How can the contemporary idea of neural gain and alertness be assayed with low cost, deployable measures? Late 20th century work on ADHD response readiness featured clever studies about the modulation of performance by event rate (160, 161). Subsequently, interest shifted to reaction time variability and then to ex-Gaussian decomposition of reaction times on fast computer tasks, and the discovery of excess very slow responses associated with ADHD (162). Informative as well are well-replicated contemporaneous findings of reduced signal detection efficiency in ADHD, measured using the computational parameter d-prime on continuous performance tests (163).
Arguably the best measure in the past decade is a well established computational decomposition of fast reaction time data called the diffusion model (164). It separates the components of decision threshold, non-decision (e.g., sensory-motor) response time, and rate of information gain (called drift rate), and thus also handles speed-accuracy trade-off elegantly. The drift rate parameter reflects the rate or efficiency of information gain (related to neural gain) via a presumed process of sequential sampling of the environment by the nervous system as seen in the recurrent electrical oscillations in the brain at rest and in activity.
A series of papers in the past decade by Huang-Pollock and colleagues highlighted the utility of this approach. Karalunas and Huang-Pollock (165) showed that the drift rate parameter (slow information gain) statistically accounted for both ADHD slow reaction time and excess very slow responses, and reaction time variability, subsequently confirmed in a meta-analysis (162). Its explanatory power was somewhat better than the earlier method of looking at ex-Gaussian parameters of the RT distribution. The diffusion model also explained poor performance on executive function tasks and accounted for patterns of response on event rate tasks (166). As with other measures of cognitive function, effects are not specific to ADHD. Alertness/gain efficiency appears to be a general marker of psychopathology (167) but as a cross cutting trait may have particular utility in ADHD.
This computational approach links directly to the neural gain models in terms of microsecond information gain efficiency. Information gain is critical to moment-to-moment task as well as social adaptation. Low alertness can manifest as slower information gain during moment-to-moment adaptation to context behaviorally and cognitively, leading to mis-aligned responses in both learning and social contexts, to poor attention, and to impulsivity in conjunction with other systems.
Despite difficulties in psychophysiological measures of arousal-related measures, this perspective is broadly consistent with key findings. For example, ADHD is associated with elevated electroencephalogram (EEG) slow wave (theta band) activity suggesting lower cortical arousal and related to slow and variable responding (though in a subset and with effect size too small for diagnostics (168–170)). A more apt EEG metric for measuring neural gain may be the aperiodic exponent of the (EEG) power spectrum--it is thorught to reflect the ratio of excitation and inhibition in cortical circuits (171) or simplistically, neural noise during task. It is correlated with drift rate in the diffusion model as well as d-prime in the signal detection model (two top cognitive markers of gain), associated with ADHD, becomes less “noisy” with methylphenidate, and marks family history of ADHD when recorded in infants (172–175). In peripheral measures, pupillary dilation and pupillary oscillation studies are also consistent with alterations and LC/NE neural gain alteration in ADHD (176–178), again implying “noiser” information uptake.
Cognitive mechanisms gain support as endophenotypes using both EF and alertness. For example, we (180) asked whether EF or alertness /information gain mediate genetic effects (measured by the ADHD polygenic score) on ADHD itself. We maximized measurement reliability by creating statistical latent variables for (a) alertness (that is, the weighted combination of d-prime, drift rate, and response variability across tasks) and (b) working memory (the weighted combination of several common task) as well as response inhibition. Alertness and working memory (but not response inhibition) mediated the association of the ADHD polygenic score with ADHD symptoms.
Overall, the emergence of strong findings for alertness and neural gain opens a new avenue for ADHD cognition. In conjunction with work on EF and delay reward discounting, it may enable integration and a path for linkage to traits as well.
Conclusion and Recommendations
ADHD is critical as a potential gateway into other more serious behavioral and emotional complications. Identifying mechanisms and predicting its course remains critical. Heterogeneity within the ADHD population affects all areas of research as well as treatment decision making. For clinical decision making and clinical prediction, enriching and refining the ADHD phenotype with novel phenotypes measures appears both necessary and tractable.
For example, emotional profiles moderate cognitive and physiological effects (181). No bio-measure will be isomorphic with the DSM-concept of ADHD unless sub-profiles are developed using enriched trait sets as tools. But the salience of the trait profiles and in cognition of the low alertness/adaptive gain model points toward the potential for low cost, deployable and novel phenotypes to enhance understanding of ADHD. Indeed, statistical studies suggest meaningful subgroups of children within an ADHD population based on trait profiles. These in turn appear to modulate a range of cognitive and physiological findings, in some instances clarifying long-standing controversies (182). In the cognitive domain, recent advances in attentional neuroscience related to computational models of neural gain provide an integrative opportunity to unify various cognitive findings under an umbrella better anchored than was the case with older but flawed ideas of arousal.
Treatment and medication effects.
With regard to trait irritability, methylphenidate appears be helpful (183) although other work suggests it suppresses symptoms of inattention and hyperactivity more than irritability and a small trial showed that there was better improvement with combined stimulant and citalopram for severe irritability (184). Further, parent management and interventions for self-regulatoin remain helpful in this domain (114). Thus, treatment for ADHD with an eye on emotional dysregulation likely will require modifications—particularly when first line treatment disappoints--exemplifying the importance of this type of specifier or sub-presentation in a future nosology. With regard to the neurocognitive parameters, treatment studies support mechanistic utility. Methylphenidate to enhances neural gain (measured by decision performance under different conditions) (185), improves the EEG aperiodic exponent (186), and the ERP P-300 amplitude (187). It also improves classic parameters like d-prime and reaction-time variability, somewhat specifically (188).
Clinical Prediction.
Overall, a key advantage of both trait ratings and computationally decomposed reaction time measures is their low cost and hence field deployability for prediction analytics and clinical treatment matching. In addition to potential specifiers for ADHD using clinical features such as cognitive disengagement syndrome or callous-unemotional traits, the potential for novel phenotypes to enhance ADHD conceptualization and clinical care is highlighted in two domains.
First, temperament measures of emotional regulation, including both negative emotions, positive emotions, and irritability (conceived either as a negative valence emotion or as frustrative approach) can characterize both early precursors as well as important course modifiers (relevant clinical subtypes or profiles) and predictors for ADHD. This has implications for the entire developmental course of externalizing and mood disorders in this population. Further, work on alternative ratings measures of impulsivity, ego-under-control, ego resilience, and related traits are also likely to be useful here. Inclusion of temperament traits or profiles enhances prediction of clinical outcome (117–119, 189). These efforts can be aided by recent measure refinement made to be available reliable, valid, and brief scales with established predictive power. These include recent work updating the Rothbart temperament scales by Karalunas and colleagues (190, 191), as well as established work such as Eisenberg’s simplification of the Block and Block undercontrol and resilience scales (192).
Second, cognitive measures could use a fresh look for clinical prediction. Although the historical and inevitable lower correlation between laboratory measures and trait or behavior ratings (relative to ratings-to-ratings correlations) will cause these measures to have lower correlations with clinical outcomes than trait ratings do, they may be hypothesized to add important value particularly in edge cases where decision making is difficult (193). The available low-cost measures here include those for selected executive functions such as working memory and response inhibition, as well as venerable computational measures of reward temporal discounting. More emphasis should be given, however, to renewed interest in measures of information gain or (presumed) neural gain parameters such as d’ and drift rate discussed earlier. These can be recovered from reaction time sequences in brief tasks and open integrative opportunities for process understanding.
Conclusion.
All of the cross cutting clinical, trait, and cognitive features are non-specific to ADHD or any other disorder. Rather, they are useful for refining phenotype description into unique profiles and specifiers that enhance clinical prediction and understanding. For this same reason, they are less useful in isolation and will be most useful when combined with with ADHD ADHD symptom profiles to enhance forward prediction of clinical course and treatment response decisions for clinical-level problems. In practical application in a future DSM, it is not necessarily clear that new clinical diagnostic criteria are needed although in a longer time frame that may prove appropriate. At this juncture, refinemnets to specifiers and presentations may be a prudent next step yet dramatically enhance understanding and care delivery.
In conclusion, ADHD phenotypes characterization and refinement is needed to further energize and clarify the burgeoning clinical and mechanistic work on ADHD and to inform the coming wave of clinical prediction models using advanced analytics. Phenotype refinement using simple dispositional trait measures should help clarify mechanistic and physiological findings, assist in early neurodevelopmental studies of developmental pathways and early outcome targets for etiological studies, account for heterogeneity of findings in mechanistic and treatment studies, and assist in the next generation of A/I powered clinical prediction and machine learning models.
Acknowledgements:
National Institute of Mental Health (NIMH) U01 MH135970
Footnotes
Disclosures: Dr. Nigg reports no financial relationships with commercial interests.
References
- 1.Kessler RC, Adler LA, Berglund P, Green JG, McLaughlin KA, Fayyad J, et al. The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Med. 2014;44(8):1779–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Treur JL, Demontis D, Smith GD, Sallis H, Richardson TG, Wiers RW, et al. Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization. Addict Biol. 2019:e12849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Riglin L, Leppert B, Dardani C, Thapar AK, Rice F, O’Donovan MC, et al. ADHD and depression: investigating a causal explanation. Psychol Med. 2020:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Groenman AP, Janssen TWP, Oosterlaan J. Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(7):556–69. [DOI] [PubMed] [Google Scholar]
- 6.Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Forte A, Orri M, Galera C, Pompili M, Turecki G, Boivin M, et al. Developmental trajectories of childhood symptoms of hyperactivity/inattention and suicidal behavior during adolescence. Eur Child Adolesc Psychiatry. 2020;29(2):145–51. [DOI] [PubMed] [Google Scholar]
- 8.Sun S, Kuja-Halkola R, Faraone SV, D’Onofrio BM, Dalsgaard S, Chang Z, et al. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry. 2019;76(11):1141–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017;9(1):47–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Beauchaine TP, Zisner AR, Sauder CL. Trait Impulsivity and the Externalizing Spectrum. Annu Rev Clin Psychol. 2017;13:343–68. [DOI] [PubMed] [Google Scholar]
- 11.Nigg JT. Annual Research Review: On the relations among self-regulation, self-control, executive functioning, effortful control, cognitive control, impulsivity, risk-taking, and inhibition for developmental psychopathology. J Child Psychol Psychiatry. 2017;58(4):361–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24(4):562–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.van der Laan CM, Ip HF, Schipper M, Hottenga JJ, St Pourcain B, Zayats T, et al. Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes. Nat Genet. 2025;57(10):2427–35. [DOI] [PubMed] [Google Scholar]
- 14.Pereira-Sanchez V, Castellanos FX. Neuroimaging in attention-deficit/hyperactivity disorder. Curr Opin Psychiatry. 2021;34(2):105–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Townend S, Staginnus M, Gao Y, Alexander N, Arolt V, Banaschewski T, et al. Shared and distinct alterations in brain structure of youth with internalizing or externalizing disorders: Findings from the ENIGMA Antisocial Behavior, ADHD, MDD, and Anxiety Working Groups. Biol Psychiatry. 2025. [DOI] [PubMed] [Google Scholar]
- 16.Mooney MA, Hermosillo RJM, Feczko E, Miranda-Dominguez O, Moore LA, Perrone A, et al. Cumulative Effects of Resting-State Connectivity Across All Brain Networks Significantly Correlate with Attention-Deficit Hyperactivity Disorder Symptoms. J Neurosci. 2024;44(10). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cecil CAM, Nigg JT. Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential. Mol Diagn Ther. 2022;26(6):581–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Meijer M, Sudre G, Ahn K, Fu MPY, Shaw P. Brain region and cell type-specific DNA methylation profiles in association with ADHD. Sci Rep. 2025;15(1):35078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schuurmans IK, Smajlagic D, Baltramonaityte V, Malmberg ALK, Neumann A, Creasey N, et al. Genetic susceptibility to neurodevelopmental conditions associates with neonatal DNA methylation patterns in the general population: an individual participant data meta-analysis. Biol Psychiatry. 2025. [DOI] [PubMed] [Google Scholar]
- 20.Schuurmans IK, Mulder RH, Baltramonaityte V, Lahtinen A, Qiuyu F, Rothmann LM, et al. Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. Mol Psychiatry. 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Momany AM, Kamradt JM, Ullsperger JM, Elmore AL, Nigg JT, Nikolas MA. Sex moderates the impact of birth weight on child externalizing psychopathology. J Abnorm Psychol. 2017;126(2):244–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Martel MM. Sexual selection and sex differences in the prevalence of childhood externalizing and adolescent internalizing disorders. Psychol Bull. 2013;139(6):1221–59. [DOI] [PubMed] [Google Scholar]
- 23.Del Giudice M, Barrett ES, Belsky J, Hartman S, Martel MM, Sangenstedt S, et al. Individual differences in developmental plasticity: A role for early androgens? Psychoneuroendocrinology. 2018;90:165–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Martel MM, Eng AG, Nirjar U, Petersen MK, Ramirez MP, Litteral CA, et al. Hormonal effects on externalizing problems in females across the lifespan. Front Neuroendocrinol. 2025;78:101206. [DOI] [PubMed] [Google Scholar]
- 25.Hinshaw SP, Nguyen PT, O’Grady SM, Rosenthal EA. Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2022;63(4):484–96. [DOI] [PubMed] [Google Scholar]
- 26.Hill DM, Sibley MH, Stein MA, Leviyah X. Longitudinal Patterns of Community-Based Treatment Utilization Among Ethnically and Racially Diverse Adolescents with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2024;34(3):119–26. [DOI] [PubMed] [Google Scholar]
- 27.Slobodin O, Masalha R. Challenges in ADHD care for ethnic minority children: A review of the current literature. Transcult Psychiatry. 2020;57(3):468–83. [DOI] [PubMed] [Google Scholar]
- 28.Shalaby N, Sengupta S, Williams JB. Large-scale analysis reveals racial disparities in the prevalence of ADHD and conduct disorders. Sci Rep. 2024;14(1):25123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cénat JM, Kokou-Kpolou CK, Blais-Rochette C, Morse C, Vandette MP, Dalexis RD, et al. Prevalence of ADHD among Black Youth Compared to White, Latino and Asian Youth: A Meta-Analysis. J Clin Child Adolesc Psychol. 2024;53(3):373–88. [DOI] [PubMed] [Google Scholar]
- 30.Nigg JT. Getting Ahead of ADHD: What Next-Generation Science Says about Treatments That Work—and How You Can Make Them Work for Your Child: Guilford Press; 2017. [Google Scholar]
- 31.Zulauf-McCurdy CA, LaCount PA, Shelton CR, Morrow AS, Zhao XA, Russell D, et al. Systematic Review and Meta-Analyses: Safety and Efficacy of Complementary and Alternative Treatments for Pediatric Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2023;44(4):e322–e32. [DOI] [PubMed] [Google Scholar]
- 32.Sibley MH, Kennedy TM, Swanson JM, Arnold LE, Jensen PS, Hechtman LT, et al. Characteristics and Predictors of Fluctuating Attention-Deficit/Hyperactivity Disorder in the Multimodal Treatment of ADHD (MTA) Study. J Clin Psychiatry. 2024;85(4). [DOI] [PubMed] [Google Scholar]
- 33.Van Meter AR, Sibley MH, Vandana P, Birmaher B, Fristad MA, Horwitz S, et al. The stability and persistence of symptoms in childhood-onset ADHD. Eur Child Adolesc Psychiatry. 2024;33(4):1163–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Craig SG, Goulter N, Moretti MM. A Systematic Review of Primary and Secondary Callous-Unemotional Traits and Psychopathy Variants in Youth. Clin Child Fam Psychol Rev. 2021;24(1):65–91. [DOI] [PubMed] [Google Scholar]
- 35.Tomlinson RC, Hyde LW, Dotterer HL, Klump KL, Burt SA. Parenting moderates the etiology of callous-unemotional traits in middle childhood. J Child Psychol Psychiatry. 2022;63(8):912–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Waschbusch DA, Babinski DE, Fosco WD, Haas SM, Waxmonsky JG, Garon N, et al. Inhibitory Control, Conduct Problems, and Callous Unemotional Traits in Children with ADHD and Typically Developing Children. Dev Neuropsychol. 2022;47(1):42–59. [DOI] [PubMed] [Google Scholar]
- 37.Masi G, Fantozzi P, Muratori P, Bertolucci G, Tacchi A, Villafranca A, et al. Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD. Compr Psychiatry. 2020;100:152178. [DOI] [PubMed] [Google Scholar]
- 38.Carson RC. Dilemmas in the pathway of the DSM-IV. J Abnorm Psychol. 1991;100(3):302–7. [DOI] [PubMed] [Google Scholar]
- 39.Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Michelini G, Palumbo IM, DeYoung CG, Latzman RD, Kotov R. Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience. Clin Psychol Rev. 2021;86:102025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Nigg JT. Temperament and developmental psychopathology. J Child Psychol Psychiatry. 2006;47(3–4):395–422. [DOI] [PubMed] [Google Scholar]
- 42.Nigg JT. Considerations toward an epigenetic and common pathways theory of mental disorder. J Psychopathol Clin Sci. 2023;132(3):297–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Achenbach TM. Bottom-Up and Top-Down Paradigms for Psychopathology: A Half-Century Odyssey. Annu Rev Clin Psychol. 2020;16:1–24. [DOI] [PubMed] [Google Scholar]
- 44.Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol. 2012;121(4):991–1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Nigg JT, Sibley MH, Thapar A, Karalunas SL. Development of ADHD: Etiology, Heterogeneity, and Early Life Course. Annu Rev Dev Psychol. 2020;2(1):559–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Frick PJ, Nigg JT. Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder. Annu Rev Clin Psychol. 2012;8:77–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Thapar A, Cooper M, Rutter M. Neurodevelopmental disorders. Lancet Psychiatry. 2017;4(4):339–46. [DOI] [PubMed] [Google Scholar]
- 48.Yu Q, Peterson EO, Parker AJ, Briggs-Gowan MJ, Wakschlag LS, Wiggins JL. Developmental shifts in irritable behaviors from preschool to school age: Longitudinal network analysis of heterotypic and homotypic continuity. Int J Behav Dev. 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Finlay-Jones AL, Ang JE, Brook J, Lucas JD, MacNeill LA, Mancini VO, et al. Systematic Review and Meta-Analysis: Early Irritability as a Transdiagnostic Neurodevelopmental Vulnerability to Later Mental Health Problems. J Am Acad Child Adolesc Psychiatry. 2024;63(2):184–215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wakschlag LS, Perlman SB, Blair RJ, Leibenluft E, Briggs-Gowan MJ, Pine DS. The Neurodevelopmental Basis of Early Childhood Disruptive Behavior: Irritable and Callous Phenotypes as Exemplars. Am J Psychiatry. 2018;175(2):114–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Burt SA. The Genetic, Environmental, and Cultural Forces Influencing Youth Antisocial Behavior Are Tightly Intertwined. Annu Rev Clin Psychol. 2022;18:155–78. [DOI] [PubMed] [Google Scholar]
- 52.Burt SA. Do etiological influences on aggression overlap with those on rule breaking? A meta-analysis. Psychol Med. 2013;43(9):1801–12. [DOI] [PubMed] [Google Scholar]
- 53.Nikolas MA, Burt SA. Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol. 2010;119(1):1–17. [DOI] [PubMed] [Google Scholar]
- 54.Nigg J, Nikolas M, Burt SA. Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9):863–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Claussen AH, Holbrook JR, Hutchins HJ, Robinson LR, Bloomfield J, Meng L, et al. All in the Family? A Systematic Review and Meta-analysis of Parenting and Family Environment as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children. Prev Sci. 2024;25(Suppl 2):249–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hinshaw SP, Arnold LE. Attention-deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: evidence, paradox, and challenge. Wiley Interdiscip Rev Cogn Sci. 2015;6(1):39–52. [DOI] [PubMed] [Google Scholar]
- 57.de la Paz L, Mooney MA, Ryabinin P, Neighbor C, Antovich D, Nigg JT, et al. Youth Polygenic Scores, Youth ADHD Symptoms, and Parenting Dimensions: An Evocative Gene-Environment Correlation Study. Res Child Adolesc Psychopathol. 2023;51(5):665–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Cunningham CE, Barkley RA. The interactions of normal and hyperactive children with their mothers in free play and structured tasks. Child Dev. 1979;50(1):217–24. [PubMed] [Google Scholar]
- 59.Manzari N, Matvienko-Sikar K, Baldoni F, O’Keeffe GW, Khashan AS. Prenatal maternal stress and risk of neurodevelopmental disorders in the offspring: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2019;54(11):1299–309. [DOI] [PubMed] [Google Scholar]
- 60.Momany AM, Kamradt JM, Nikolas MA. A Meta-Analysis of the Association Between Birth Weight and Attention Deficit Hyperactivity Disorder. J Abnorm Child Psychol. 2018;46(7):1409–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Serati M, Barkin JL, Orsenigo G, Altamura AC, Buoli M. Research Review: The role of obstetric and neonatal complications in childhood attention deficit and hyperactivity disorder - a systematic review. J Child Psychol Psychiatry. 2017;58(12):1290–300. [DOI] [PubMed] [Google Scholar]
- 62.Wiggs K, Elmore AL, Nigg JT, Nikolas MA. Pre- and Perinatal Risk for Attention-Deficit Hyperactivity Disorder: Does Neuropsychological Weakness Explain the Link? J Abnorm Child Psychol. 2016;44(8):1473–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Bjorkenstam E, Bjorkenstam C, Jablonska B, Kosidou K. Cumulative exposure to childhood adversity, and treated attention deficit/hyperactivity disorder: a cohort study of 543 650 adolescents and young adults in Sweden. Psychol Med. 2018;48(3):498–507. [DOI] [PubMed] [Google Scholar]
- 64.Goodlad JK, Marcus DK, Fulton JJ. Lead and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms: a meta-analysis. Clin Psychol Rev. 2013;33(3):417–25. [DOI] [PubMed] [Google Scholar]
- 65.Nigg JT, Elmore AL, Natarajan N, Friderici KH, Nikolas MA. Variation in an Iron Metabolism Gene Moderates the Association Between Blood Lead Levels and Attention-Deficit/Hyperactivity Disorder in Children. Psychol Sci. 2016;27(2):257–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Nigg JT. Lead and attention deficit hyperactivity disorder. In: Nriagu J, editor. Encyclopedia of Environmental Health (2nd edition). London: Elsevier; 2019. p. 33–8. [Google Scholar]
- 67.Rivollier F, Krebs MO, Kebir O. Perinatal Exposure to Environmental Endocrine Disruptors in the Emergence of Neurodevelopmental Psychiatric Diseases: A Systematic Review. Int J Environ Res Public Health. 2019;16(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Myhre O, Låg M, Villanger GD, Oftedal B, Øvrevik J, Holme JA, et al. Early life exposure to air pollution particulate matter (PM) as risk factor for attention deficit/hyperactivity disorder (ADHD): Need for novel strategies for mechanisms and causalities. Toxicol Appl Pharmacol. 2018;354:196–214. [DOI] [PubMed] [Google Scholar]
- 69.Thapar A, Rutter M. Do natural experiments have an important future in the study of mental disorders? Psychol Med. 2019;49(7):1079–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.D’Onofrio BM, Class QA, Rickert ME, Larsson H, Långström N, Lichtenstein P. Preterm birth and mortality and morbidity: a population-based quasi-experimental study. JAMA Psychiatry. 2013;70(11):1231–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Musser ED, Willoughby MT, Wright S, Sullivan EL, Stadler DD, Olson BF, et al. Maternal prepregnancy body mass index and offspring attention-deficit/hyperactivity disorder: a quasi-experimental sibling-comparison, population-based design. J Child Psychol Psychiatry. 2017;58(3):240–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Larsson H, Sariaslan A, Långström N, D’Onofrio B, Lichtenstein P. Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study. J Child Psychol Psychiatry. 2014;55(5):428–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Mooney MA, Ryabinin P, Morton H, Selah K, Gonoud R, Kozlowski M, et al. Joint polygenic and environmental risks for childhood attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom dimensions. JCPP Adv. 2023;3(2):e12152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Mooney MA, Ryabinin P, Nousen E, Tipsord J, Dieckmann NF, Karalunas SL, et al. Sibling Control Analysis of Perinatal Health and Family Environment Factors Related to Childhood ADHD Symptoms. medRxiv. 2025. [Google Scholar]
- 75.Ribasés M, Mitjans M, Hartman CA, Soler Artigas M, Demontis D, Larsson H, et al. Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes. Neurosci Biobehav Rev. 2023;153:105313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Lahey BB, Schaughency EA, Strauss CC, Frame CL. Are attention deficit disorders with and without hyperactivity similar or dissimilar disorders? J Am Acad Child Psychiatry. 1984;23(3):302–9. [DOI] [PubMed] [Google Scholar]
- 77.McBurnett K, Pfiffner LJ, Frick PJ. Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo. J Abnorm Child Psychol. 2001;29(3):207–13. [DOI] [PubMed] [Google Scholar]
- 78.Ercan ES, Suren S, Bacanlı A, Yazici KU, Callı C, Ozyurt O, et al. Decreasing ADHD phenotypic heterogeneity: searching for neurobiological underpinnings of the restrictive inattentive phenotype. Eur Child Adolesc Psychiatry. 2016;25(3):273–82. [DOI] [PubMed] [Google Scholar]
- 79.Becker SP. Cognitive disengagement syndrome: A construct at the crossroads. Am Psychol. 2025;80(5):812–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Tamm L, Epstein JN, Orban SA, Kofler MJ, Peugh JL, Becker SP. Neurocognition in children with cognitive disengagement syndrome: accurate but slow. Child Neuropsychol. 2024;30(2):221–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Durak S, Tahıllıoğlu A, Yazan Songür Ç, Çoban M, Varol B, Ercan ES. Differentiating pure cognitive disengagement syndrome and attention-deficit/hyperactivity disorder-restrictive inattentive presentation with respect to depressive symptoms, autistic traits, and neurocognitive profiles. Appl Neuropsychol Child. 2025:1–11. [DOI] [PubMed] [Google Scholar]
- 82.Ünsel-Bolat G, Ercan ES, Bolat H, Süren S, Bacanlı A, Yazıcı KU, et al. Comparisons between sluggish cognitive tempo and ADHD-restrictive inattentive presentation phenotypes in a clinical ADHD sample. Atten Defic Hyperact Disord. 2019;11(4):363–72. [DOI] [PubMed] [Google Scholar]
- 83.Goh PK, Martel MM, Barkley RA. Clarifying ADHD and Sluggish Cognitive Tempo Item Relations with Impairment: A Network Analysis. J Abnorm Child Psychol. 2020;48(8):1047–61. [DOI] [PubMed] [Google Scholar]
- 84.Borgert M, Melin A, Hollander AC, Rahman S. Prenatal maternal PTSD as a risk factor for offspring ADHD: A register-based Swedish cohort study of 553 766 children and their mothers. Eur Psychiatry. 2024;67(1):e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Tu HF, Skalkidou A, Lindskog M, Gredebäck G. Maternal childhood trauma and perinatal distress are related to infants’ focused attention from 6 to 18 months. Sci Rep. 2021;11(1):24190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Van den Bergh BRH, van den Heuvel MI, Lahti M, Braeken M, de Rooij SR, Entringer S, et al. Prenatal developmental origins of behavior and mental health: The influence of maternal stress in pregnancy. Neurosci Biobehav Rev. 2020;117:26–64. [DOI] [PubMed] [Google Scholar]
- 87.Sullivan EL, Molloy KR, Dunn GA, Balanzar AL, Young AS, Loftis JM, et al. Adipokines measured during pregnancy and at birth are associated with infant negative affect. Brain Behav Immun. 2024;120:34–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Gustafsson HC, Dunn GA, Mitchell AJ, Holton KF, Loftis JM, Nigg JT, et al. The association between heightened ADHD symptoms and cytokine and fatty acid concentrations during pregnancy. Front Psychiatry. 2022;13:855265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Gustafsson HC, Sullivan EL, Battison EAJ, Holton KF, Graham AM, Karalunas SL, et al. Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation. Brain Behav Immun. 2020;89:350–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Sullivan EL, Nousen EK, Chamlou KA. Maternal high fat diet consumption during the perinatal period programs offspring behavior. Physiol Behav. 2014;123:236–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Sullivan EL, Holton KF, Nousen EK, Barling AN, Sullivan CA, Propper CB, et al. Early identification of ADHD risk via infant temperament and emotion regulation: a pilot study. J Child Psychol Psychiatry. 2015;56(9):949–57. [DOI] [PubMed] [Google Scholar]
- 92.Miller M, Arnett AB, Shephard E, Charman T, Gustafsson HC, Joseph HM, et al. Delineating early developmental pathways to ADHD: Setting an international research agenda. JCPP Adv. 2023;3(2):e12144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Finik J, Buthmann J, Zhang W, Go K, Nomura Y. Placental Gene Expression and Offspring Temperament Trajectories: Predicting Negative Affect in Early Childhood. J Abnorm Child Psychol. 2020;48(6):783–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Epigenetics Jubair H. and Environmental Exposures in Early Neurodevelopment: Implications for Pediatric Neurological Disorders. Sage Open Pediatr. 2025;12:30502225251380331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Rothbart MK. Becoming who we are : temperament and personality in development. New York: Guilford Press; 2011. xi, 324 p. p. [Google Scholar]
- 96.Miller NV, Hane AA, Degnan KA, Fox NA, Chronis-Tuscano A. Investigation of a developmental pathway from infant anger reactivity to childhood inhibitory control and ADHD symptoms: interactive effects of early maternal caregiving. J Child Psychol Psychiatry. 2019;60(7):762–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Rabinovitz BB, O’Neill S, Rajendran K, Halperin JM. Temperament, executive control, and attention-deficit/hyperactivity disorder across early development. J Abnorm Psychol. 2016;125(2):196–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Goldsmith HH, Lemery KS, Essex MJ. Temperament as a Liability Factor for Childhood Behavioral Disorders: The Concept of Liability. Behavior genetics principles: Perspectives in development, personality, and psychopathology. Decade of behavior. Washington, DC, US: American Psychological Association; 2004. p. 19–39. [Google Scholar]
- 99.Gustafsson HC, Nolvi S, Sullivan EL, Rasmussen JM, Gyllenhammer LE, Entringer S, et al. Early development of negative and positive affect: Implications for ADHD symptomatology across three birth cohorts. Dev Psychopathol. 2021;33(5):1837–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Jonas K, Kochanska G. An Imbalance of Approach and Effortful Control Predicts Externalizing Problems: Support for Extending the Dual-Systems Model into Early Childhood. J Abnorm Child Psychol. 2018;46(8):1573–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Miller NV, Degnan KA, Hane AA, Fox NA, Chronis-Tuscano A. Infant temperament reactivity and early maternal caregiving: independent and interactive links to later childhood attention-deficit/hyperactivity disorder symptoms. J Child Psychol Psychiatry. 2019;60(1):43–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Heinze H, Daseking M, Gawrilow C, Gunzenhauser C, Karbach J, Ulitzka B, et al. Reactive temperament and self-regulation in preschool: Unique constellations impacting psychopathology. Appl Neuropsychol Child. 2025:1–17. [DOI] [PubMed] [Google Scholar]
- 103.Tsukui N, Nomura Y, Newcorn JH, Takahashi N, Ishikawa-Omori Y, Nakayasu C, et al. Temperament Profiles at Age 18 Months as Distinctive Predictors of Elevated ASD- and ADHD-Trait Scores and Their Co-Occurrence at Age 8–9: HBC Study. Res Child Adolesc Psychopathol. 2025;53(4):511–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Willoughby MT, Gottfredson NC, Stifter CA. Observed temperament from ages 6 to 36 months predicts parent- and teacher-reported attention-deficit/hyperactivity disorder symptoms in first grade. Dev Psychopathol. 2017;29(1):107–20. [DOI] [PubMed] [Google Scholar]
- 105.Einziger T, Levi L, Zilberman-Hayun Y, Auerbach JG, Atzaba-Poria N, Arbelle S, et al. Predicting ADHD Symptoms in Adolescence from Early Childhood Temperament Traits. J Abnorm Child Psychol. 2018;46(2):265–76. [DOI] [PubMed] [Google Scholar]
- 106.Eisenberg N, Valiente C, Spinrad TL, Liew J, Zhou Q, Losoya SH, et al. Longitudinal relations of children’s effortful control, impulsivity, and negative emotionality to their externalizing, internalizing, and co-occurring behavior problems. Dev Psychol. 2009;45(4):988–1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Perroud N, Hasler R, Golay N, Zimmermann J, Prada P, Nicastro R, et al. Personality profiles in adults with attention deficit hyperactivity disorder (ADHD). BMC Psychiatry. 2016;16:199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Martel MM, Roberts B, Gremillion M, von Eye A, Nigg JT. External validation of bifactor model of ADHD: explaining heterogeneity in psychiatric comorbidity, cognitive control, and personality trait profiles within DSM-IV ADHD. J Abnorm Child Psychol. 2011;39(8):1111–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.De Pauw SS, Mervielde I. The role of temperament and personality in problem behaviors of children with ADHD. J Abnorm Child Psychol. 2011;39(2):277–91. [DOI] [PubMed] [Google Scholar]
- 110.Martel MM. Research review: a new perspective on attention-deficit/hyperactivity disorder: emotion dysregulation and trait models. J Child Psychol Psychiatry. 2009;50(9):1042–51. [DOI] [PubMed] [Google Scholar]
- 111.Martel MM, Nigg JT. Child ADHD and personality/temperament traits of reactive and effortful control, resiliency, and emotionality. J Child Psychol Psychiatry. 2006;47(11):1175–83. [DOI] [PubMed] [Google Scholar]
- 112.Martel MM, Nigg JT, von Eye A. How do trait dimensions map onto ADHD symptom domains? J Abnorm Child Psychol. 2009;37(3):337–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Nigg JT, John OP, Blaskey LG, Huang-Pollock CL, Willcutt EG, Hinshaw SP, et al. Big five dimensions and ADHD symptoms: links between personality traits and clinical symptoms. J Pers Soc Psychol. 2002;83(2):451–69. [DOI] [PubMed] [Google Scholar]
- 114.Leibenluft E, Allen LE, Althoff RR, Brotman MA, Burke JD, Carlson GA, et al. Irritability in Youths: A Critical Integrative Review. Am J Psychiatry. 2024;181(4):275–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Nigg JT, Karalunas SL, Mooney MA, Wilmot B, Nikolas MA, Martel MM, et al. The Oregon ADHD-1000: A new longitudinal data resource enriched for clinical cases and multiple levels of analysis. Dev Cogn Neurosci. 2023;60:101222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Karalunas SL, Antovich D, Miller N, Nigg JT. Prospective prediction of developing internalizing disorders in ADHD. J Child Psychol Psychiatry. 2023;64(5):768–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Karalunas SL, Gustafsson HC, Fair D, Musser ED, Nigg JT. Do we need an irritable subtype of ADHD? Replication and extension of a promising temperament profile approach to ADHD subtyping. Psychol Assess. 2019;31(2):236–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Blanken TF, Courbet O, Franc N, Albajara Sáenz A, Van Someren EJW, Peigneux P, et al. Is an irritable ADHD profile traceable using personality dimensions? Replicability, stability, and predictive value over time of data-driven profiles. Eur Child Adolesc Psychiatry. 2021;30(4):633–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Karalunas SL, Fair D, Musser ED, Aykes K, Iyer SP, Nigg JT. Subtyping attention-deficit/hyperactivity disorder using temperament dimensions: toward biologically based nosologic criteria. JAMA Psychiatry. 2014;71(9):1015–24. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 120.Martel MM. Dispositional Trait Types of ADHD in Young Children. J Atten Disord. 2016;20(1):43–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Smith TE, Martel MM. Trait-Based Profiles of ADHD in Adolescents and Young Adults. J Clin Child Adolesc Psychol. 2019;48(3):440–54. [DOI] [PubMed] [Google Scholar]
- 122.Martel MM, Goth-Owens T, Martinez-Torteya C, Nigg JT. A person-centered personality approach to heterogeneity in attention-deficit/hyperactivity disorder (ADHD). J Abnorm Psychol. 2010;119(1):186–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Karalunas SL, Antovich D, Goh PK, Martel MM, Tipsord J, Nousen EK, et al. Longitudinal network model of the co-development of temperament, executive functioning, and psychopathology symptoms in youth with and without ADHD. Dev Psychopathol. 2021;33(5):1803–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Nigg JT, Karalunas SL, Gustafsson HC, Bhatt P, Ryabinin P, Mooney MA, et al. Evaluating chronic emotional dysregulation and irritability in relation to ADHD and depression genetic risk in children with ADHD. J Child Psychol Psychiatry. 2020;61(2):205–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Barkley RA. Deficient emotional self-regulation: A core component of attention-deficit/hyperactivity disorder. Journal of ADHD and Related Disorders. 2010;1:5–37. [Google Scholar]
- 126.Ochsner KN, Gross JJ. The cognitive control of emotion. Trends Cogn Sci. 2005;9(5):242–9. [DOI] [PubMed] [Google Scholar]
- 127.Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001;24:167–202. [DOI] [PubMed] [Google Scholar]
- 128.Ellis LK, Rothbart MK, Posner MI. Individual differences in executive attention predict self-regulation and adolescent psychosocial behaviors. Ann N Y Acad Sci. 2004;1021:337–40. [DOI] [PubMed] [Google Scholar]
- 129.Rueda MR, Posner MI, Rothbart MK. The development of executive attention: contributions to the emergence of self-regulation. Dev Neuropsychol. 2005;28(2):573–94. [DOI] [PubMed] [Google Scholar]
- 130.Diamond A Executive functions. Annu Rev Psychol. 2013;64:135–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Patros CH, Alderson RM, Kasper LJ, Tarle SJ, Lea SE, Hudec KL. Choice-impulsivity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): A meta-analytic review. Clin Psychol Rev. 2016;43:162–74. [DOI] [PubMed] [Google Scholar]
- 132.Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 2005;28(3):397–419; discussion −68. [DOI] [PubMed] [Google Scholar]
- 133.Fowles DC. Arousal, Gray’s theory of anxiety, and the etiology of psychopathy. Biol Psychol. 2024;188:108772. [DOI] [PubMed] [Google Scholar]
- 134.Zuckerman M Psychobiology of personality. New York: Cambridge University Press; 1991. [Google Scholar]
- 135.Eysenck HJ. The biological basis of personality. Springfield, IL: Thomas; 1967. [Google Scholar]
- 136.Strelau J Temperament, personality, and arousal. London: Academic Press; 1983. [Google Scholar]
- 137.Zuckerman M Sensation seeking: A comparative approach to a human trait. Behavioral and Brain Sciences. 1984;7(3):413–71. [Google Scholar]
- 138.Gray JA. Pavlov’s Typology: A translation from the Russian and an introduction 1964. [Google Scholar]
- 139.Gray JA, McNaughton N. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. 2nd ed: Oxford University Press; 2000. [Google Scholar]
- 140.Fowles DC. The three arousal model: implications of gray’s two-factor learning theory for heart rate, electrodermal activity, and psychopathy. Psychophysiology. 1980;17(2):87–104. [DOI] [PubMed] [Google Scholar]
- 141.Quay HC. Inhibition and attention deficit hyperactivity disorder. J Abnorm Child Psychol. 1997;25(1):7–13. [DOI] [PubMed] [Google Scholar]
- 142.Quay HC. Theories of ADDH. J Am Acad Child Adolesc Psychiatry. 1988;27(2):262–3. [DOI] [PubMed] [Google Scholar]
- 143.Satterfield JH, Dawson ME. Electrodermal correlates of hyperactivity in children. Psychophysiology. 1971;8(2):191–7. [DOI] [PubMed] [Google Scholar]
- 144.Zentall S Optimal stimulation as theoretical basis of hyperactivity. Am J Orthopsychiatry. 1975;45(4):549–63. [DOI] [PubMed] [Google Scholar]
- 145.Zentall SS, Zentall TR. Optimal stimulation: a model of disordered activity and performance in normal and deviant children. Psychol Bull. 1983;94(3):446–71. [PubMed] [Google Scholar]
- 146.Söderlund GBW, Hadjikhani N, Thorsson M, S ES, Claesdotter-Knutsson E, Gustafsson P, et al. Sensory white noise in clinical ADHD: Who benefits from noise, and who performs worse? Scand J Child Adolesc Psychiatr Psychol. 2024;12(1):92–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Söderlund G, Sikström S, Smart A. Listen to the noise: noise is beneficial for cognitive performance in ADHD. J Child Psychol Psychiatry. 2007;48(8):840–7. [DOI] [PubMed] [Google Scholar]
- 148.Baijot S, Slama H, Söderlund G, Dan B, Deltenre P, Colin C, et al. Neuropsychological and neurophysiological benefits from white noise in children with and without ADHD. Behav Brain Funct. 2016;12(1):11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Nigg JT, Bruton A, Kozlowski MB, Johnstone JM, Karalunas SL. Systematic Review and Meta-Analysis: Do White Noise or Pink Noise Help With Task Performance in Youth With Attention-Deficit/Hyperactivity Disorder or With Elevated Attention Problems? J Am Acad Child Adolesc Psychiatry. 2024;63(8):778–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Egeland J, Lund O, Kowalik-Gran I, Aarlien AK, Söderlund GBW. Effects of auditory white noise stimulation on sustained attention and response time variability. Front Psychol. 2023;14:1301771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Petersen SE, Posner MI. The attention system of the human brain: 20 years after. Annu Rev Neurosci. 2012;35:73–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Parikh V, Bangasser DA. Cholinergic Signaling Dynamics and Cognitive Control of Attention. Curr Top Behav Neurosci. 2020;45:71–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Thiele A, Bellgrove MA. Neuromodulation of Attention. Neuron. 2018;97(4):769–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Torres AS, Robison MK, Brewer GA. The role of the LC-NE system in attention: From cells, to systems, to sensory-motor control. Neurosci Biobehav Rev. 2025;175:106233. [DOI] [PubMed] [Google Scholar]
- 155.Galgani A, Bartolini E, D’Amora M, Faraguna U, Giorgi FS. The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence. Int J Mol Sci. 2023;24(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Ferguson KA, Cardin JA. Mechanisms underlying gain modulation in the cortex. Nat Rev Neurosci. 2020;21(2):80–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28:403–50. [DOI] [PubMed] [Google Scholar]
- 158.Eldar E, Cohen JD, Niv Y. The effects of neural gain on attention and learning. Nat Neurosci. 2013;16(8):1146–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Hauser TU, Fiore VG, Moutoussis M, Dolan RJ. Computational Psychiatry of ADHD: Neural Gain Impairments across Marrian Levels of Analysis. Trends Neurosci. 2016;39(2):63–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Metin B, Roeyers H, Wiersema JR, van der Meere J, Sonuga-Barke E. A meta-analytic study of event rate effects on Go/No-Go performance in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;72(12):990–6. [DOI] [PubMed] [Google Scholar]
- 161.van der Meere J, Sergeant J. Focused attention in pervasively hyperactive children. J Abnorm Child Psychol. 1988;16(6):627–39. [DOI] [PubMed] [Google Scholar]
- 162.Karalunas SL, Geurts HM, Konrad K, Bender S, Nigg JT. Annual research review: Reaction time variability in ADHD and autism spectrum disorders: measurement and mechanisms of a proposed trans-diagnostic phenotype. J Child Psychol Psychiatry. 2014;55(6):685–710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Huang-Pollock CL, Karalunas SL, Tam H, Moore AN. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnorm Psychol. 2012;121(2):360–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Ratcliff R, Rouder JN. Modeling response times for two-choice decisions. Psychological Science. 1998;9(5):347–56. [Google Scholar]
- 165.Karalunas SL, Huang-Pollock CL. Integrating impairments in reaction time and executive function using a diffusion model framework. J Abnorm Child Psychol. 2013;41(5):837–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Huang-Pollock C, Ratcliff R, McKoon G, Shapiro Z, Weigard A, Galloway-Long H. Using the Diffusion Model to Explain Cognitive Deficits in Attention Deficit Hyperactivity Disorder. J Abnorm Child Psychol. 2017;45(1):57–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Sripada C, Weigard A. Impaired Evidence Accumulation as a Transdiagnostic Vulnerability Factor in Psychopathology. Front Psychiatry. 2021;12:627179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Slater J, Joober R, Koborsy BL, Mitchell S, Sahlas E, Palmer C. Can electroencephalography (EEG) identify ADHD subtypes? A systematic review. Neurosci Biobehav Rev. 2022;139:104752. [DOI] [PubMed] [Google Scholar]
- 169.Arns M, Conners CK, Kraemer HC. A decade of EEG Theta/Beta Ratio Research in ADHD: a meta-analysis. J Atten Disord. 2013;17(5):374–83. [DOI] [PubMed] [Google Scholar]
- 170.Boxum M, Voetterl H, van Dijk H, Gordon E, DeBeus R, Arnold LE, et al. Challenging the Diagnostic Value of Theta/Beta Ratio: Insights From an EEG Subtyping Meta-Analytical Approach in ADHD. Appl Psychophysiol Biofeedback. 2024. [DOI] [PubMed] [Google Scholar]
- 171.Gao R, Peterson EJ, Voytek B. Inferring synaptic excitation/inhibition balance from field potentials. Neuroimage. 2017;158:70–8. [DOI] [PubMed] [Google Scholar]
- 172.Karalunas SL, Ostlund BD, Alperin BR, Figuracion M, Gustafsson HC, Deming EM, et al. Electroencephalogram aperiodic power spectral slope can be reliably measured and predicts ADHD risk in early development. Dev Psychobiol. 2022;64(3):e22228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Ostlund BD, Alperin BR, Drew T, Karalunas SL. Behavioral and cognitive correlates of the aperiodic (1/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD. Dev Cogn Neurosci. 2021;48:100931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Robertson MM, Furlong S, Voytek B, Donoghue T, Boettiger CA, Sheridan MA. EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood. J Neurophysiol. 2019;122(6):2427–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Pertermann M, Bluschke A, Roessner V, Beste C. The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(8):743–50. [DOI] [PubMed] [Google Scholar]
- 176.Kleberg JL, Frick MA, Brocki KC. Eye-movement indices of arousal predict ADHD and comorbid externalizing symptoms over a 2-year period. Sci Rep. 2023;13(1):4767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Boxhoorn S, Bast N, Supèr H, Polzer L, Cholemkery H, Freitag CM. Pupil dilation during visuospatial orienting differentiates between autism spectrum disorder and attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2020;61(5):614–24. [DOI] [PubMed] [Google Scholar]
- 178.Privitera CM, Noah S, Carney T, Klein SA, Lenartowicz A, Hinshaw SP, et al. Pupillary unrest is attenuated in attention deficit hyperactivity disorder (ADHD). Neurosci Lett. 2025;851:138148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Tamm L, Dudley JA, Karalunas SL, Simon JO, Maloney TC, Atluri G, et al. Exploring the neural basis of reaction time variability in ADHD: The importance of examining data at the trial level. Neuroimage Rep. 2025;5(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 180.Nigg JT, Gustafsson HC, Karalunas SL, Ryabinin P, McWeeney SK, Faraone SV, et al. Working Memory and Vigilance as Multivariate Endophenotypes Related to Common Genetic Risk for Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2018;57(3):175–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Figuracion MT, Kozlowski MB, Macknyk KS, Heise MB, Pieper SM, Alperin BR, et al. The Relationship Between Emotion Dysregulation and Error Monitoring in Adolescents with ADHD. Res Child Adolesc Psychopathol. 2024;52(4):605–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Karalunas SL, Weigard A, Alperin B. Emotion-Cognition Interactions in Attention-Deficit/Hyperactivity Disorder: Increased Early Attention Capture and Weakened Attentional Control in Emotional Contexts. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5(5):520–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Winters DE, Fukui S, Leibenluft E, Hulvershorn LA. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder. J Child Adolesc Psychopharmacol. 2018;28(5):298–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Towbin K, Vidal-Ribas P, Brotman MA, Pickles A, Miller KV, Kaiser A, et al. A Double-Blind Randomized Placebo-Controlled Trial of Citalopram Adjunctive to Stimulant Medication in Youth With Chronic Severe Irritability. J Am Acad Child Adolesc Psychiatry. 2020;59(3):350–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Trempler I, Heimsath A, Nieborg J, Bradke B, Schubotz RI, Ohrmann P. Ignore the glitch but mind the switch: Positive effects of methylphenidate on cognition in attention deficit hyperactivity disorder are related to prediction gain. J Psychiatr Res. 2022;156:177–85. [DOI] [PubMed] [Google Scholar]
- 186.Gao Y, Roessner V, Stock AK, Mückschel M, Colzato L, Hommel B, et al. Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity. Int J Neuropsychopharmacol. 2024;27(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Peisch V, Rutter T, Wilkinson CL, Arnett AB. Sensory processing and P300 event-related potential correlates of stimulant response in children with attention-deficit/hyperactivity disorder: A critical review. Clin Neurophysiol. 2021;132(4):953–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Bron TI, Bijlenga D, Boonstra AM, Breuk M, Pardoen WF, Beekman AT, et al. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study. Eur Neuropsychopharmacol. 2014;24(4):519–28. [DOI] [PubMed] [Google Scholar]
- 189.Rutter TM, Arnett AB. Temperament Traits Mark Liability for Coexisting Psychiatric Symptoms in Children With Elevated ADHD Symptoms. J Atten Disord. 2021;25(13):1871–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Kozlowski MB, Morton HE, Nigg JT, Karalunas SL. Reproducible structure with measurement invariance for the Parent-Report Early Adolescent Temperament Questionnaire: Findings from three independent samples. Psychol Assess. 2025;37(5):214–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Kozlowski MB, Antovich D, Karalunas SL, Nigg JT. Temperament in middle childhood questionnaire: New data on factor structure and applicability in a child clinical sample. Psychol Assess. 2022;34(12):1081–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192.Alessandri G, Luengo Kanacri BP, Eisenberg N, Zuffianò A, Milioni M, Vecchione M, et al. Prosociality during the transition from late adolescence to young adulthood: the role of effortful control and ego-resiliency. Pers Soc Psychol Bull. 2014;40(11):1451–65. [DOI] [PubMed] [Google Scholar]
- 193.Mooney MA, Neighbor C, Karalunas S, Dieckmann NF, Nikolas M, Nousen E, et al. Prediction of Attention-Deficit/Hyperactivity Disorder Diagnosis Using Brief, Low-Cost Clinical Measures: A Competitive Model Evaluation. Clin Psychol Sci. 2023;11(3):458–75. [DOI] [PMC free article] [PubMed] [Google Scholar]


